Evidence map›Paper›PMID 28683284›Full record

ReviewCell metabolism2017

Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?

Frances M Ashcroft, Maria Rohm, Anne Clark, Melissa F Brereton

Abstract readReview
In one paragraph

Review in Cell metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Article
  3. Contrasting Effects of Chronic Glucokinase Activation and Inhibition on Pancreatic Beta-Cell Function.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Metabolic Characteristics of Gestational Diabetes Mellitus and the Effects on Pregnancy Outcomes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Frances M AshcroftDepartment of Physiology, Anatomy, and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK. Electronic address: frances.ashcroft@dpag.ox.c.uk.
Maria RohmDepartment of Physiology, Anatomy, and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK.
Anne ClarkOxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.
Melissa F BreretonDepartment of Physiology, Anatomy, and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK.
University of Oxford · GB

Funding

European Research Council 322620Wellcome Trust 084655Wellcome Trust 089795
6 · The paper itself

Abstract

Elevated plasma glucose leads to pancreatic β cell dysfunction and death in type 2 diabetes. Glycogen accumulation, due to impaired metabolism, contributes to this "glucotoxicity" via dysregulated biochemical pathways promoting β cell dysfunction. Here, we review emerging data, and re-examine published findings, on the role of glycogen in β cells in normoglycemia and in diabetes.

Indexed as

AnimalsBlood GlucoseDiabetes Mellitus, Type 2GlycogenGlycogen Storage DiseaseHumansInsulin-Secreting CellsSignal TransductionBlood GlucoseGlycogendiabetesglycogeninsulinpancreatic β cell

Identifiers

PMID28683284
PMCPMC5890904
OpenAlexW2727176663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.